Last Updated December 17, 2009
Small sum, big deal
It’s a company you may never have heard of, but Russia’s Human Stem Cell Institute wants to reopen the country’s IPO market and become a global biotech player. Founder Artur Isaev tells Tim Burke how he plans to do it.
